학술논문
A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with schizophrenia
Document Type
Article
Source
In: International Clinical Psychopharmacology . (International Clinical Psychopharmacology, 2018, 33(2):79-87)
Subject
Language
English
ISSN
14735857
02681315
02681315